Log in
Enquire now
‌

US Patent 11123338 C-met modulator pharmaceutical compositions

Patent 11123338 was granted and assigned to Exelixis Ltd on September, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Exelixis Ltd
0
Current Assignee
‌
Exelixis Ltd
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
111233380
Patent Inventor Names
Khalid Shah0
Jo Ann Wilson0
Date of Patent
September 21, 2021
0
Patent Application Number
201912200
Date Filed
December 20, 2019
0
Patent Citations Received
‌
US Patent 11504363 Method of treating cancer and bone cancer pain
Patent abstract

Pharmaceutical compositions and unit dosage forms comprising Compound (I) are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11123338 C-met modulator pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.